EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer.

Tan X, Xiao GY, Wang S, Shi L, Zhao Y, Liu X, Yu J, Russell WK, Creighton CJ, Kurie JM
J Clin Invest. 2023 Apr 3;133(7):e165863. doi: 10.1172/JCI165863. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.